Analyzing RECKITT BENCKISER under value investing prospective it comes with a discount price compared to its intrinsic value. The company keep revenue growing even with pandemic environment and growth will continue on 2021 and 2022. But this is not the main topic to highlight because future growth of the company will be based on strong investment in R&D made in 2020.
The company instead of cutting const in a difficult year focused in R&D with the highest expense amount in is history to put itself in the perfect place to be to take advantage in 2021 and 2022 from pandemic environment.
The company has already a strong position on hygiene products nd this will be the strongest pillar for future growth
From a discounted cash flow model I setted target price for 2022 and 2023 and the line that links those target is my intrinsic value line.
At same time we can see from the chart that there is a strong support area and while price is near this area we the max advantage from our investment.
Possible upside is up to 30% - 50% for an already well positioned and established business.
On top of it company pays regular, sustainable ad growing dividend.
The company instead of cutting const in a difficult year focused in R&D with the highest expense amount in is history to put itself in the perfect place to be to take advantage in 2021 and 2022 from pandemic environment.
The company has already a strong position on hygiene products nd this will be the strongest pillar for future growth
From a discounted cash flow model I setted target price for 2022 and 2023 and the line that links those target is my intrinsic value line.
At same time we can see from the chart that there is a strong support area and while price is near this area we the max advantage from our investment.
Possible upside is up to 30% - 50% for an already well positioned and established business.
On top of it company pays regular, sustainable ad growing dividend.